Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With SchizophreniaCognition Disorders, Cognitive Dysfunction, Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, cognitive disorder, psychiatric disorder, schizophreniaNot yet recruitingPhase 32026-05-13NCT07084831

3 results · Page 1 of 1

Swipe the table sideways for more columns.

16 results · Page 1 of 1

Swipe the table sideways for more columns.